Showing results (1621-1630 of 1,671) with videos related to
Sort By:
Pageof 168
The Lancet. Diabetes & Endocrinology|June 4, 2017
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohortTracy A Williams, Jacques W M Lenders, Paolo Mulatero, et al.Surgery|June 29, 2021
Multiple endocrine neoplasia type 1 in children and adolescents: Clinical features and treatment outcomesOmair A Shariq, Kate E Lines, Katherine A English, et al.World Journal of Surgery|January 16, 2008
Surgery for Cushing's syndrome: an historical review and recent ten-year experienceJohn R Porterfield, Geoffrey B Thompson, William F Young, et al.Nature Medicine|January 9, 2018
Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuryEnrico Velardi, Jennifer J Tsai, Stefan Radtke, et al.Cancer Research|June 5, 2013
PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHDArnab Ghosh, Amanda M Holland, Yildirim Dogan, et al.Nature Medicine|April 11, 2018
Corrigendum: Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuryEnrico Velardi, Jennifer J Tsai, Stefan Radtke, et al.The Journal of Experimental Medicine|May 2, 2012
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantationRobert R Jenq, Carles Ubeda, Ying Taur, et al.Blood|November 2, 2018
Nrf2 regulates CD4+ T cell-induced acute graft-versus-host disease in miceJennifer J Tsai, Enrico Velardi, Yusuke Shono, et al.Psychiatric Services (Washington, D.C.)|January 25, 2023
Youth Mental Health Screening and Linkage to CareNicole R Karcher, Ramona Hicks, Jason Schiffman, et al.Nature Cancer|February 5, 2022
The CIP2A-TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancerSalomé Adam, Silvia Emma Rossi, Nathalie Moatti, et al.Pageof 168